Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limite
Recalled April 16, 2025 · FDA recall D-0335-2025 · Glenmark Pharmaceuticals Inc., USA
Hazard
CGMP Deviations · FDA Class II
Units
N/A
Sold at
U.S. Nationwide
Description
CGMP Deviations
Product
Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →